MENLO PARK, Calif.--Progenitor has been issued a patent that relates to the genes encoding the human leptin receptor and naturally occurring human leptin receptor variants, expression vectors, and genetically engineered cells incorporating the genes and methods for producing leptin receptor molecules in genetically engineered cells.
The patent is the second issued to Progenitor. The company has two other allowed patents, and another four pending.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
